Vaccines Market 2016-2022: By Type (Monovalent, Multivalent), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines), Disease Indication (Pneumococcal Disease, DTP) & End User - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Vaccines Market (2016-2022)" report to their offering.

The vaccination saves millions of lives including adults, children, and animals, and provides them a better and healthier life. Globally, development of efficient and advanced vaccines, rise in the awareness among people regarding the benefits of immunization, increasing government initiatives across the globe, growing prevalence of diseases, and increasing demand for better healthcare infrastructure are the prime growth drivers of the vaccines market.

In addition, an increase in adoption of vaccines in emerging economies such as China, India and others, will create new opportunities for the vaccines market. However, higher cost of research and development, and risk of side effects of vaccines are the key restraints for the vaccines market.

Geographically, North America dominated the vaccines market, with approximately half of the world's procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have the fastest growth, owing to a rapidly increasing population, rise in consumer awareness, growing disposable income & healthcare expenditure, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the end users, pediatrics segment has the highest market share in the vaccines market due to higher prevalence of diseases.

Companies Mentioned:

  • Medimmune, LLC. (A Subsidiary of Astrazeneca)
  • Astellas Pharma Inc.
  • Serum Institute of India
  • Emergent Biosolutions, Inc.
  • Merck & Co., Inc.
  • Johnson & Johnson
  • Sanofi Pasteur
  • CSL Limited
  • Pfizer, Inc.
  • Glaxosmithkline, PLC.

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Vaccines Market, By Type

7. Vaccines Market, By Technology

8. Vaccines Market, By Diseases Indication

9. Vaccines Market, By End-User

10. Vaccines Market, By Geography

11. Vaccines - Entropy

12. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

13. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/zw7jlg/vaccines_market

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Vaccines